CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
2.35
0.41 (21.13%)
At close: Aug 15, 2025, 3:59 PM
2.00
-14.89%
After-hours: Aug 15, 2025, 07:47 PM EDT

CASI Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
10.9M 13.47M 16.54M 9.53M 12.2M 17.08M 19.98M 16.91M 16.59M 47.11M 26.74M 18.86M 29.26M 38.7M 53.13M 60.36M 68.12M
Short-Term Investments
1.8M 2.62M 4.28M 3.19M 7.46M 13.69M 15.62M 21.88M 27.7M 4.22M 6.31M 5.71M 8.22M 9.87M 9.5M 12.59M 10.95M
Long-Term Investments
1.91M 1.72M 2.25M 1.77M 1.69M 1.69M 3.61M 3.64M 7.43M 7.46M 39.32M 41.19M 40.32M 40.13M 34.18M 34.68M 34.87M
Other Long-Term Assets
590K 587K 702K 692K 702K 766K 1.61M 1.21M 1.15M 1.06M 1.39M 1.12M 1.26M 2.18M 1.5M 506K 1.18M
Receivables
7.6M 15.35M 11.14M 7.74M 6.07M 10.14M 11.66M 12.53M 11.11M 12.97M 12.56M 10.26M 10.09M 9.8M 5.42M 5.77M 5.84M
Inventory
4.15M 5.25M 12.93M 14.61M 15.42M 15.88M 8.83M 7.77M 8.56M 6.14M 5.77M 5.79M 3.72M 1.91M 1.73M 3.48M 2.99M
Other Current Assets
2.71M 2.89M 2.27M 2.11M 2M 2.56M 2.03M 1.91M 2.63M 2.98M 2.5M n/a 1.4M n/a 2.19M n/a n/a
Total Current Assets
27.16M 39.58M 47.15M 37.2M 43.15M 59.34M 58.12M 61M 66.59M 73.42M 55.61M 42.28M 52.7M 61.97M 71.96M 83.5M 89.01M
Property-Plant & Equipment
10.92M 11.36M 12.4M 10.25M 10.85M 11.63M 10.62M 11.49M 12.41M 13.23M 21.53M 23.32M 23.39M 21.82M 16.28M 13.14M 10.2M
Goodwill & Intangibles
233K 238K 1.12M 1.36M 1.62M 1.84M 273K 537K 812K 1.06M 10.05M 10.95M 11.9M 12.2M 12.36M 12.69M 12.83M
Total Long-Term Assets
13.66M 13.9M 16.46M 16.09M 14.86M 15.92M 16.11M 16.87M 21.8M 22.81M 72.29M 76.57M 76.87M 76.33M 64.31M 61.02M 59.08M
Total Assets
40.82M 53.67M 63.62M 51.27M 58.01M 75.27M 74.23M 77.87M 88.4M 96.23M 127.91M 118.86M 129.56M 138.3M 136.27M 144.53M 148.09M
Account Payables
1.2M 2.72M 1.76M 792K 583K 4.44M 2.56M 2.37M 2.83M 3.29M 3.1M 4.6M 7.17M 2.22M 6.32M 5.52M 5.74M
Deferred Revenue
n/a 2.47M n/a n/a n/a 2.54M n/a n/a n/a 2.62M 16.98M 57K 2.82M 2.83M 2.34M 2.35M 2.33M
Short-Term Debt
18.49M 18.39M n/a n/a n/a n/a n/a n/a n/a n/a 3M 1M n/a n/a 1.08M 466K 1.99M
Other Current Liabilities
n/a 10.31M n/a n/a n/a 8.48M n/a n/a n/a 8.04M 10.81M 12.62M 5.49M 519K n/a 1.55M n/a
Total Current Liabilities
33.71M 36.45M 14.74M 9.58M 8.54M 16.73M 11.83M 11.91M 14.04M 17M 29.75M 13.18M 13.87M 13.19M 9.96M 10.02M 9.97M
Long-Term Debt
n/a n/a 19.12M 18.46M 18.59M 18.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
15.18M 12.84M 15.91M 14.2M 15.41M 13.87M 11.97M 12.12M 12.13M 11.82M 11.82M 12.56M 13.26M 13.22M 14.46M 14.65M 13.6M
Total Long-Term Liabilities
15.18M 15.37M 35.03M 32.67M 34M 34.38M 11.97M 12.12M 12.13M 12.3M 14.94M 16.08M 16.98M 17.15M 16.8M 17.01M 15.93M
Total Liabilities
48.89M 51.82M 49.77M 42.25M 42.54M 51.1M 23.79M 24.03M 26.17M 29.3M 44.69M 29.25M 30.85M 30.34M 26.76M 27.03M 25.9M
Total Debt
18.49M 22.14M 19.12M 18.46M 18.59M 18.89M n/a n/a n/a 1.34M 4.56M 2.9M 1.88M 2.17M 1.08M 2.01M 1.99M
Common Stock
2K 2K 2K 1K 1K 1K 1K 1K 1K 1K 1.37M 1.37M 1.37M 1.4M 1.4M 1.4M 1.4M
Retained Earnings
-710.83M -700.08M -685.71M -677.31M -670.35M -660.82M -655.67M -651.8M -642.32M -637.16M -624.86M -620.57M -613.63M -605.64M -599.97M -590.26M -583.84M
Comprehensive Income
-2.23M -1.77M -1.47M -1.42M -1.1M -1.2M -1.62M -1.59M -613K -703K -1.95M -160K 2.13M 1.95M 1.17M 1.16M 485K
Shareholders Equity
-8.07M 1.85M 13.85M 9.02M 15.47M 24.16M 28.79M 32.23M 39.58M 44.57M 61.71M 66.94M 74.99M 84.5M 86.61M 94.8M 100.03M
Total Investments
3.72M 4.34M 6.52M 4.97M 9.15M 15.37M 19.23M 25.52M 35.13M 11.69M 45.63M 46.89M 48.55M 50M 43.68M 47.27M 45.82M